skip to content

Cambridge Public Policy SRI


The 2018 CeBIL Annual Symposium is open to anyone interested in law and biomedical research, including academic researchers, biotech and pharma industry professionals, and independent/academic lawyers. It is hosted by the Centre for Law Medicine and Life Sciences (on behalf of the CeBIL collaborative project) and includes an exciting range of speakers and panellists, so we are keen to reach as wide an audience as possible. We are aiming for an interdisciplinary audience and early career researchers are particularly encouraged to attend.

This one-day symposium, hosted by The Centre for Law, Medicine and Life Sciences (LML) and The Center for Advanced Studies in Biomedical Innovation Law (CeBIL), aims to tackle some of the challenging issues raised by black-box precision medicine, particularly for legal and regulatory frameworks. Black-box precision medicine is an exciting new frontier in health care diagnostics, harnessing the power of big data and artificial intelligence to examine newly available troves of health data, including genomic sequences, patient clinical care records, and the results of diagnostic tests.

This symposium features an international showcase of speakers and panellists from industry, academia, FDA/MHRA and legal services. 

Confirmed speakers include:

Dr Alberto Gutierrez (FDA 2009-2017)

Prof Glenn Cohen (Harvard), Emeritus Prof Chris Lowe (Cambridge Academy of

Therapeutic Sciences)

Prof Timo Minssen (Copenhagen)

Prof Mateo Aboy (Cambridge)

Dr John Liddicoat (Cambridge)

Dr Stuart Hogarth (Cambridge)

Nicholson Price (Michigan)

Jacob Sherkow (New York).


Lunch and refreshments will be provided and the event will conclude with a networking and drinks reception.

To register, please go to 

and for enquiries please email Carmen Smith in the CATS team at:

Friday, 7 September, 2018 - 18:25
Contact name: 
Carmen Smith
Event location: 
Christ's College, Cambridge